eMedicine Specialties > Radiology > Pediatrics

Caffey Disease

Author: Bonnie C Davis, MD, Fellow in Body Imaging, Department of Radiology, University of Maryland Medical System at Baltimore
Coauthor(s): Welansa Asrat, MD, Staff Physician, Departments of Medicine and Pediatrics, Saint Vincent's Medical Center
Contributor Information and Disclosures

Updated: Jun 7, 2007

Introduction

Background

Caffey disease, or infantile cortical hyperostosis, is a benign, rare, proliferating bone disease affecting infants. Caffey and Silverman first reported this disease as a distinct entity in 1945.

Classically, Caffey disease occurs in the early part of the first year of life (<5 mo). It is characterized by a clinical triad (fever, soft-tissue swelling, and hyperirritability) and a clinching radiographic picture of underlying cortical hyperostosis (thickening or bony expansion). In addition to the skeleton, the adjacent fascia, muscles, and connective tissues are also involved. Some have suggested that Caffey disease has a predilection for patients with immunodeficient disorders.

Two forms of Caffey disease have been described: prenatal and infantile. The prenatal form is rare and has a poor prognosis. The prenatal form has been described as a more severe, congenital form of Caffey disease that is probably inherited as an autosomal recessive trait. Patients present with major angulation of the long bones, generalized symmetrical involvement of the skeleton, and polyhydramnios. Because the prenatal form is a rare presentation of Caffey disease, the remaining discussion in this article, except in the differential diagnostic section, pertains to the more common infantile form.

Recently, hyperostosis has been reported in patients receiving therapeutic doses of prostaglandin E. Prostaglandins E1 and E2 maintain patency of the ductus arteriosus in infants born with ductus-dependent cyanotic congenital heart disease. This treatment helps provide adequate time for the infant to mature in preparation of surgical intervention. However, cortical hyperostosis can occur as a complication of long-term treatment (4-6 wk). The bony changes appear to be dose and duration dependent. Regression of the bony changes occurs on the discontinuation of treatment.

Overall, the age of onset, clinical signs, laboratory results, and the typical radiographic features are the clues for the correct diagnosis of Caffey disease.

Pathophysiology

Pathologic phases

The histological analysis of areas of cortical thickening in Caffey disease reveals progressive remodeling (depletion) of the original cortical bone out of existence, with abnormal deposition of hyperplastic immature (though normal) lamellar bone. Additional findings of the surrounding tissues include thickening of the periosteum; intense proliferation of subperiosteal cells; and fibrosis of bone marrow. Collectively, the histopathological findings suggest a common pathway that leads to an inflammatory reaction without specific recognizable markers for Caffey disease.Three pathologic phases of the skeletal and soft-tissue manifestations of Caffey disease have been described: early, subacute, and late.

Early phase

The early phase is characterized by an acute intraperiosteal inflammatory reaction consisting of edema and cellular infiltration with subsequent thickening of the periosteum. The inflammatory process can extend into the neighboring soft tissues, and cortical resorption may be present.

Subacute phase

In the subacute phase, inflammation diminishes, the periosteum thickens, and ossifying periostitis subsequently develops (see Image 2). Beneath the periosteum, layers of immature lamellar bone are produced; these can be exuberant in nature. Bony deposition may occur in the neighboring soft tissues.

Late phase

The late phase involves the removal of peripheral bone, beginning along the inner surface and extending outwardly. Cortical remodeling may also be observed.

Pathogenesis

Various theories have been proposed regarding the inciting event responsible for the inflammatory reaction of the periosteum and adjacent connective tissues in Caffey disease. One such theory is the obliteration of small arteries in the region of bone and fascial lesions due to the proliferation of the intima of arterioles. This theory has suggested to some investigators that hypoxia may be the initial event that stimulates osteogenic activity and the remaining inflammatory manifestations of the disease. Although the end result is an abnormal mass of bone formation that blends with the bony cortex (hence, cortical hyperostosis), histologic evaluation of the affected bone during the early phase of the disease shows that the original underlying cortical tissue is progressively remodeled out of existence; this finding suggests that osteoclastic activity is present as well. Simultaneously, a fibrotic reaction of the bone marrow also occurs.

Yet another theory proposes a link between Caffey disease and immaturity of the central nervous system with associated undeveloped myelinization of the peripheral nerves. It seems more than coincidental that the surrounding structures of the mandible—the most commonly involved bone in Caffey disease—are innervated by sensory branches of the trigeminal nerve, which is the last of the cranial nerves to start and subsequently become fully myelinated. Following this order of logic, the trigeminal nerve is presumably most sensitive to pathologies resulting in disorders of demyelinization. Further support for this theory is derived from the radiographic findings that demonstrate marked similarity in the posttraumatic exuberant periosteal reaction seen in sensory-deprived children with demyelinization disorders and in the periosteal changes seen in Caffey disease.

Etiology

Although the etiology of Caffey disease remains unclear, many clinical and pathologic features are suggestive of an inflammatory process. However, other features of the disease support infectious, hereditary, and possibly allergic etiologies.

Features suggesting an inflammatory etiology include the following: (1) acute inflammatory changes present in the periosteum during the initial stage; (2) in severe cases, clinical improvement, after the administration of steroids, coupled with the lack of response to antibiotics; and (3) exact replication of hyperostosis in patients receiving prostaglandins to treat ductus-dependent cyanotic congenital heart disease. (Actually, naproxen, an inhibitor of prostaglandin synthesis, has been shown to be beneficial in relieving symptoms and shortening the duration and severity of active hyperostosis.)

Features suggesting an infectious etiology include the following: (1) severe and protracted fever, (2) leukocytosis, (3) elevated sedimentation rate, (4) increased levels of gamma globulins (consistent with in utero viral infection), (5) increased levels of C-reactive protein, (6) pleural exudates, and (7) cases clustered in time and location. A theory that suggests expression of a latent infectious agent (eg, virus) has been proposed. The virus, which inserts itself into the host genome, would subsequently express itself, generation after generation; certain environmental factors may promote this process.

Features suggesting a hereditary etiology include the following: (1) disease present in siblings and families and (2) documentation of an autosomal dominant pattern of inheritance with incomplete penetrance and variable (clinical) expressivity.

Features suggesting an allergic etiology include the following: (1) allergy to altered collagen tissue, which then promotes alterations in the surrounding osseous, muscular, soft tissues, and vascular structures; (2) documented cases of a high familial occurrence of asthma in families with Caffey disease also; and (3) reported cases with a history of allergy to milk.

Frequency

International

Caffey disease has a worldwide distribution. Both sporadic and familial occurrences are reported, with sporadic cases more common than familial ones. The number of sporadic cases has substantially declined since 1960. Currently, the only cases reported are the occasional polyostotic familial cases.

Mortality/Morbidity

Mortality and Morbidity are both rare occurrences associated with Caffey disease. Resnick states "Rarely, a severely affected infant will die, usually as a result of a secondary infection."1,2

Race

All races are affected.

Sex

Caffey disease affects boys and girls equally.

Age

Patients are almost always younger than 5 months. The average age at onset is 9-10 weeks.

Anatomy

In varying layers of thickness, normal bone tissue (membranous and cartilaginous) is composed of an inner spongy bone surrounded by an outside layer of compact bone (see Image 1). In long bones, the spongy bone is removed to form a hollowed space called the medullary cavity. This cavity is lined by a thin cellular layer called endosteum and filled with a specialized type of connective tissue called marrow. The periosteum, a connective-tissue membrane, covers the surface of the bone (excluding the articular cartilage) and connects it with the surrounding soft tissues.

Normal bone tissue is maintained by a balance between bone erosion (absorption) and bone deposition (formation). This equilibrium is disturbed in response to pathological changes such as inflammation, vascular obstruction or tumor proliferation, usually visualized as one process (bone formation vs erosion) predominating over the other.

The cells of the endosteum and of the deeper layers of the periosteum are the osteogenic tissues of the body. It is primarily this osteogenic capability of the periosteum that produces subperiosteal new bone formation in Caffey disease. This process is not to be confused with normal (physiologic) periosteal new bone formation. In actively growing infants, the transient, frequently symmetrical, physiologic periosteal reaction of long tubular bones may be radiographically present at approximately age 2-6 months. Any other detection of periosteal new bone formation should be considered abnormal.

Presentation

Overall, the age of onset, clinical signs, laboratory results, and typical radiographic features are clues for the correct diagnosis of Caffey disease.

Signs and symptoms

The typical clinical triad includes fever of abrupt onset, hyperirritability, and soft-tissue swelling (especially over the mandible). Other clinical features may include pallor, painful pseudoparalysis of the affected area, and pleurisy. Clinical examination reveals a palpable, hard and tender soft-tissue mass over the area of cortical thickening. The soft-tissue swelling precedes the bony change.

Laboratory data

Laboratory studies may show an elevated erythrocyte sedimentation rate (ESR), an elevated serum alkaline phosphatase level, moderate leukocytosis, thrombocytosis, and iron-deficiency anemia. Anemia is thought to be due to widespread myelofibrosis.

Clinical course

The clinical course of Caffey disease is highly variable, ranging from self-limited to protracted.

The self-limited course of disease is the most common pattern. The course is slow, occurring over months to years (usually before age 2 y), and the disease spontaneously resolves. The resolution of radiographic findings commences weeks to months after the initial presentation, with complete resolution in 6 months to 1 year.

The protracted course of disease is marked by recurrent and persistent episodes ranging from weeks to months interspersed with remissions and relapses. As the pain and swelling overlying the bony abnormality subsides in 1 anatomic location, pain and swelling appears at another site. A marked delay in the musculoskeletal development and crippling deformities can occur in some cases depending on the location of the lesion. Examples include facial asymmetry (mandibular lesion), exophthalmos (orbital lesion), ipsilateral diaphragmatic paralysis (scapular lesion), and bowing of the limbs. Possible residual radiographic changes include diaphyseal expansion and/or longitudinal overgrowth (leading to leg-length discrepancy), cortical thinning, bowing deformities, and osseous bridging with contiguous bones (eg, ribs, radius, ulna).

Compared with the sporadic type, the hereditary type is marked by an earlier age of onset (at 6-8 wk) and less mandibular involvement but greater involvement of the lower extremity.

Some authorities believe that Caffey disease is not a single disease or infection, but rather a syndrome of common manifestations with heterogeneous causes. In other words, the clinical, radiographic, and laboratory findings may represent a common pathway resulting from various stimuli.

Differential diagnoses and other problems to be considered

Clinical differential diagnoses include osteomyelitis, parotitis and parotid gland abscess (with a monostotic mandibular presentation), and a bone tumor of the affected area.

In the prenatal form, differential diagnoses include hypophosphatasia; camptomelic dysplasia, which is associated with hypoplastic fibulae and talipes equinovarus, but not periosteal new bone formation; and osteogenesis imperfecta. Regarding hypophosphatasia, poor mineralization is not present in Caffey disease. Regarding osteogenesis imperfecta, Caffey disease is less likely in cases of fractures.

Differential diagnoses for the classic infantile form are shown in the Table below.

Differential Diagnoses of Classic Infantile Form of Caffey Disease

Open table in new window

Table
Differential DiagnosisFeatures Resembling those of Caffey DiseaseFeatures Distinct from those of Caffey Disease
Hypervitaminosis APeriosteal new bone formation typically along the diaphysis of long bonesCharacteristic clinical/radiographic findings at the end of the first year, mandible not involved, increased blood level of vitamin A
Healing scurvySubperiosteal new bone formation during healing phaseUncommon before age 4 months, irregularity of the metaphysis, presence of subperiosteal hemorrhage, decreased alkaline phosphatase levels; marked osteopenia
Healing ricketsStripelike density that parallels the outer cortical margin of long bones, resembling a periosteal reactionSplaying and irregularity of the metaphysis, slower resolution of clinical and radiographic findings
Trauma, especially battered child syndromeCalcified subperiosteal densityFractures predominate, metaphyseal irregularity, subperiosteal hemorrhage, bruises and head injuries
OsteomyelitisSimilar MRI findings of soft tissue and marrow edema, periosteal reactionUsually only affects 1 bone for a given clinical period, bone destruction and sclerotic bony changes
LeukemiaPronounced periosteal bone formationLytic bone lesions, radiolucent metaphyseal bands
NeuroblastomaPronounced periosteal bone formationLytic bone lesions, radiolucent metaphyseal bands, increased levels of vanillylmandelic acid levels in the urine
Osteogenesis imperfectaPeriosteal new bone formationMandible not involved, fractures present, persistence of the original cortical tissue histologically, blue sclerae and delicate skin
SyphilisPeriosteal new bone formationCan be associated with lytic bone lesions, especially in the medial aspect of the proximal tibial metaphysis; confirm by serologic testing
Camurati-Engelmann diseaseCortical thickeningSymmetrical involvement of the hands and feet
HyperphosphatemiaCortical thickening, increased alkaline phosphatase levelsBowing of the long bones
Hypertrophic osteoarthropathyPeriosteal reaction of long tubular bonesAssociation with clubbing/ lung disease
Bone tumorPeriosteal new bone formation, similar appearance of microscopic proliferation of subperiosteal cellsMalignant features of bone tumors including tumor mass; solitary lesion
Complications of long-term prostaglandin therapy (ie, prostaglandin periostitis)Marked resemblance to Caffey disease radiographicallyLacks the mandibular involvement, history of prostaglandin treatment for cardiac disease
Differential DiagnosisFeatures Resembling those of Caffey DiseaseFeatures Distinct from those of Caffey Disease
Hypervitaminosis APeriosteal new bone formation typically along the diaphysis of long bonesCharacteristic clinical/radiographic findings at the end of the first year, mandible not involved, increased blood level of vitamin A
Healing scurvySubperiosteal new bone formation during healing phaseUncommon before age 4 months, irregularity of the metaphysis, presence of subperiosteal hemorrhage, decreased alkaline phosphatase levels; marked osteopenia
Healing ricketsStripelike density that parallels the outer cortical margin of long bones, resembling a periosteal reactionSplaying and irregularity of the metaphysis, slower resolution of clinical and radiographic findings
Trauma, especially battered child syndromeCalcified subperiosteal densityFractures predominate, metaphyseal irregularity, subperiosteal hemorrhage, bruises and head injuries
OsteomyelitisSimilar MRI findings of soft tissue and marrow edema, periosteal reactionUsually only affects 1 bone for a given clinical period, bone destruction and sclerotic bony changes
LeukemiaPronounced periosteal bone formationLytic bone lesions, radiolucent metaphyseal bands
NeuroblastomaPronounced periosteal bone formationLytic bone lesions, radiolucent metaphyseal bands, increased levels of vanillylmandelic acid levels in the urine
Osteogenesis imperfectaPeriosteal new bone formationMandible not involved, fractures present, persistence of the original cortical tissue histologically, blue sclerae and delicate skin
SyphilisPeriosteal new bone formationCan be associated with lytic bone lesions, especially in the medial aspect of the proximal tibial metaphysis; confirm by serologic testing
Camurati-Engelmann diseaseCortical thickeningSymmetrical involvement of the hands and feet
HyperphosphatemiaCortical thickening, increased alkaline phosphatase levelsBowing of the long bones
Hypertrophic osteoarthropathyPeriosteal reaction of long tubular bonesAssociation with clubbing/ lung disease
Bone tumorPeriosteal new bone formation, similar appearance of microscopic proliferation of subperiosteal cellsMalignant features of bone tumors including tumor mass; solitary lesion
Complications of long-term prostaglandin therapy (ie, prostaglandin periostitis)Marked resemblance to Caffey disease radiographicallyLacks the mandibular involvement, history of prostaglandin treatment for cardiac disease

Preferred Examination

The general radiographic findings of Caffey disease reflect the features described below.

The bones most commonly affected are flat bones: mandible (75% involvement), clavicle, rib (especially the lateral arches), scapula, skull, and ilium.

The tubular bones most commonly affected are the ulna bones, which usually show asymmetric involvement.

Bones rarely affected are the vertebrae, carpus, tarsus, and phalanges. Symmetrical or asymmetrical distributions may be observed, and involvement can be monostotic and polyostotic. Tubular-bone involvement affects the diaphysis and spares the metaphysis and epiphysis.

The scapula is altered in 10% of cases, and any associated with exuberant hyperostosis may resemble neoplasm. Scapular involvement is also associated with neurologic deficit and diaphragmatic elevation.

When the ribs are affected, costal hyperostosis can be associated with an ipsilateral exudative pleural effusion. Bony rib fusion may occur and lead to scoliosis. In the forearm, when both the radius and ulna are affected, bony fusion is a particular risk and the resulting synostosis may persist after the disease resolves.

Differential Diagnoses

Other Problems to Be Considered

Clinical differential diagnoses
Osteomyelitis
Parotitis and parotid gland abscess
Bone tumor of the affected area

Prenatal form
Hypophosphatasia
Camptomelic dysplasia
Osteogenesis imperfecta

Classic infantile form
Hypervitaminosis A
Healing scurvy
Healing rickets
Trauma, especially battered child syndrome
Osteomyelitis
Leukemia
Neuroblastoma
Osteogenesis imperfecta
Syphilis
Camurati-Engelmann disease
Hyperphosphatemia
Hypertrophic osteoarthropathy
Bone tumor
Complications of long-term prostaglandin therapy (ie, prostaglandin periostitis)

More on Caffey Disease

Overview: Caffey Disease
Imaging: Caffey Disease
Follow-up: Caffey Disease
Multimedia: Caffey Disease
References

References

  1. Resnick D. Diagnosis of Bone and Joint Disorder. Vol 2. 3rd ed. Philadelphia, PA: WB Saunders Co;. 1995:610.

  2. Resnick D. Diagnosis of Bone and Joint Disorder. Vol 4. 3rd ed. Philadelphia, Pa: WB Saunders Co;. 1995:4436-42.

  3. Bernstein RM, Zaleske DJ. Familial aspects of Caffey's disease. Am J Orthop. Oct 1995;24(10):777-81. [Medline].

  4. Bykov S, Garty I, Spiegel R, et al. "Bearded infant" appearance on bone and Ga-67 scintigraphy in a child with localized mandibular Caffey's disease. Clin Nucl Med. May 2003;28(5):426-8. [Medline].

  5. Caffey J. Infantile Cortical Hyperostosis. J Pediatr. 1946;29(5):541-9.

  6. Caffey J, Silverman WA. Infantile Cortical Hyperostosis. Preliminary report on a new syndrome. Am J Roentgenol. 1945;54:1-16.

  7. Caffey's disease. Available at. www.amershamhealth.com. [Full Text].

  8. Carey BE. Neonatal cortical hyperostosis. Neonatal Netw. Oct 2000;19(7):55-7. [Medline].

  9. Drinkwater BM, Crino JP, Garcia J, et al. Recurrent severe infantile cortical hyperostosis (Caffey disease) in siblings. Prenat Diagn. Aug 1997;17(8):773-6. [Medline].

  10. Eisenberg R. Clinical Imaging: An Atlas of Differential Diagnosis. Aspen Publishers, Inc;. 1988: 680-1.

  11. Eisenberg R. Clinical Imaging: An Atlas of Differential Diagnosis. Philadelphia, Pa: Lippincott, Williams & Wilkins;. 2003:810.

  12. Finsterbush A, Rang M. Infantile cortical hyperostosis. Follow-up of 29 cases. Acta Orthop Scand. Nov 1975;46(5):727-36. [Medline].

  13. Grover SB, Taneja DK. Images in Clinical Practice. Caffey's disease. Indian Pediatr. Nov 1997;34(11):1043. [Medline].

  14. Hole J. Human Anatomy and Physiology. 2nd ed. William Brown Co;. 1978:154-8.

  15. Houston CS. Caffey's disease. Pediatr Radiol. Nov 1996;26(11):831. [Medline].

  16. Jakubikova J, Macek M, Halasova E. Swelling over the face: infantile cortical hyperostosis. Int J Pediatr Otorhinolaryngol. Apr 1994;29(2):147-50. [Medline].

  17. Kabra M, Kabra SK, Ghosh M, et al. Idiopathic cranio-osteoarthropathy. Indian Pediatr. Jun 2000;37(6):659-62. [Medline].

  18. Kirks D. Practical Pediatric Imaging: Diagnostic Radiology of Infants and Children. 2nd ed. 1991:389.

  19. Lecolier B, Bercau G, Gonzales M, et al. Radiographic, haematological, and biochemical findings in a fetus with Caffey disease. Prenat Diagn. Aug 1992;12(8):637-41. [Medline].

  20. Maclachlan AK, Gerrard JW, Houston CS, Ives EJ. Familial infantile cortical hyperostosis in a large Canadian family. Can Med Assoc J. May 1 1984;130(9):1172-4. [Medline].

  21. Pazzaglia UE, Byers PD, Beluffi G, et al. Pathology of infantile cortical hyperostosis (Caffey's disease). Report of a case. J Bone Joint Surg Am. Dec 1985;67(9):1417-26. [Medline].

  22. Quacci D, Pazzaglia UE, Dell'Orbo C, Ennas MG. Infantile cortical hyperostosis (Caffey disease): ultrastructural and immunohistochemical characterization of the peritrabecular cells. Histol Histopathol. Apr 1990;5(2):187-92. [Medline].

  23. Rayder S, Ozonoff MB, Hajedemos H. Infantile Cortical Hyperostosis. Applied Radiology. May 1992;13-16.

  24. Rogosin A, Monos T, Shulman H, et al. Caffey-Silverman syndrome (infantile cortical hyperostosis) mimicking periorbital cellulitis. J Pediatr Ophthalmol Strabismus. Jan-Feb 1999;36(1):40-1. [Medline].

  25. Saatci I, Brown JJ, McAlister WH. MR findings in a patient with Caffey's disease. Pediatr Radiol. 1996;26(1):68-70. [Medline].

  26. Sanders DG, Weijers RE. MRI findings in Caffey's disease. Pediatr Radiol. 1994;24(5):325-7. [Medline].

  27. Savarirayan R, Cormier-Daire V, Amor DJ, et al. Prenatal cortical hyperostosis (Caffey disease). Pediatr Radiol. Sep 2002;32(9):694. [Medline].

  28. Shanks SC, Kerley P. A Textbook of X-ray Diagnosis: Bones, Joints and Soft Tissues. Vol 4. 2nd ed. 1952:56, 60-1, 64, 88.

  29. Silverman F, Kuhn J. Essentials of Caffey's Pediatric X-ray Diagnosis. Mosby Year Book, Inc;. 1990:954-7.

  30. Thometz JG, DiRaimondo CA. A case of recurrent Caffey's disease treated with naproxen. Clin Orthop. Feb 1996;304-9. [Medline].

  31. Varma R, Johny VF. Infantile cortical hyperostosis. Indian Pediatr. Nov 2002;39(11):1057. [Medline].

Further Reading

Keywords

infantile cortical hyperostosis, Caffey's disease, Caffey-Silverman syndrome, prenatal Caffey disease, infantile Caffey disease, prostaglandin E, sporadic Caffey disease, familial Caffey disease

Contributor Information and Disclosures

Author

Bonnie C Davis, MD, Fellow in Body Imaging, Department of Radiology, University of Maryland Medical System at Baltimore
Bonnie C Davis, MD is a member of the following medical societies: American Roentgen Ray Society, National Medical Association, and Radiological Society of North America
Disclosure: Nothing to disclose.

Coauthor(s)

Welansa Asrat, MD, Staff Physician, Departments of Medicine and Pediatrics, Saint Vincent's Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Robert J Starshak, MD, Medical Director, Assistant Clinical Professor, Department of Radiology, Medical College of Wisconsin, Falls Medical Group
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Kieran McHugh, MBBCh, Honorary Lecturer, The Institute of Child Health; Consultant Pediatric Radiologist, Department of Radiology, Great Ormond Street Hospital for Children, London, UK
Kieran McHugh, MBBCh is a member of the following medical societies: American Roentgen Ray Society and Royal College of Radiologists
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Eugene C Lin, MD, Consulting Staff, Department of Radiology, Virginia Mason Medical Center
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, and Society of Nuclear Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.